SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-222424
Filing Date
2013-05-15
Accepted
2013-05-15 16:20:18
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d516318d10q.htm 10-Q 409267
2 EX-10.1 d516318dex101.htm EX-10.1 18994
3 EX-31.1 d516318dex311.htm EX-31.1 10377
4 EX-31.2 d516318dex312.htm EX-31.2 10122
5 EX-32.1 d516318dex321.htm EX-32.1 5588
  Complete submission text file 0001193125-13-222424.txt   3256970

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mstx-20130331.xml EX-101.INS 365044
7 XBRL TAXONOMY EXTENSION SCHEMA mstx-20130331.xsd EX-101.SCH 41668
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mstx-20130331_cal.xml EX-101.CAL 58496
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mstx-20130331_def.xml EX-101.DEF 70008
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mstx-20130331_lab.xml EX-101.LAB 282784
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mstx-20130331_pre.xml EX-101.PRE 188592
Mailing Address 12390 EL CAMINO REAL SUITE 150 SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SUITE 150 SAN DIEGO CA 92130 8585520866
Mast Therapeutics, Inc. (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32157 | Film No.: 13847400
SIC: 2834 Pharmaceutical Preparations